These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18780647)

  • 1. Serum erythropoietin and angiogenetic factors in human colorectal cancer.
    Chabowska A; Sulkowska M; Wincewicz A; Chabowski A; Mysliwiec M; Pawlak K; Koda M; Kedra B; Sulkowski S
    Prague Med Rep; 2007; 108(4):348-57. PubMed ID: 18780647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients.
    Famulski W; Sulkowska M; Wincewicz A; Kedra B; Pawlak K; Zalewski B; Sulkowski S; Koda M; Baltaziak M
    Neoplasma; 2006; 53(1):43-8. PubMed ID: 16416012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of VE-cadherin increase independently of VEGF in preoperative sera of patients with colorectal cancer.
    Sulkowska M; Famulski W; Wincewicz A; Moniuszko T; Kedra B; Koda M; Zalewski B; Baltaziak M; Sulkowski S
    Tumori; 2006; 92(1):67-71. PubMed ID: 16683386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.
    Rabascio C; Muratori E; Mancuso P; Calleri A; Raia V; Foutz T; Cinieri S; Veronesi G; Pruneri G; Lampertico P; Iavarone M; Martinelli G; Goldhirsch A; Bertolini F
    Cancer Res; 2004 Jun; 64(12):4373-7. PubMed ID: 15205354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma VEGF-A and its soluble receptor R1 correlate with the clinical stage of colorectal cancer.
    Myśliwiec P; Piotrowski Z; Zalewski B; Kukliński A; Pawlak K
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():85-7. PubMed ID: 15638384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
    Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
    Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery.
    Kirman I; Belizon A; Balik E; Feingold D; Arnell T; Horst P; Kumara S; Cekic V; Jain S; Nasar A; Whelan RL
    Eur J Surg Oncol; 2007 Dec; 33(10):1169-76. PubMed ID: 17512160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients.
    Kumar H; Heer K; Greenman J; Kerin MJ; Monson JR
    Anticancer Res; 2002; 22(3):1877-80. PubMed ID: 12168886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratinocyte growth factor induces vascular endothelial growth factor-A expression in colorectal cancer cells.
    Narita K; Fujii T; Ishiwata T; Yamamoto T; Kawamoto Y; Kawahara K; Nakazawa N; Naito Z
    Int J Oncol; 2009 Feb; 34(2):355-60. PubMed ID: 19148469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor and psychosocial factors in colorectal cancer.
    Sharma A; Greenman J; Sharp DM; Walker LG; Monson JR
    Psychooncology; 2008 Jan; 17(1):66-73. PubMed ID: 17410522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin.
    Martin TA; Watkins G; Lane J; Jiang WG
    Histopathology; 2005 Apr; 46(4):422-30. PubMed ID: 15810954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
    Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
    Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. sVE-cadherin and sCD146 serum levels in patients with multiple myeloma.
    Wrobel T; Mazur G; Wolowiec D; Jazwiec B; Sowinska E; Kuliczkowski K
    Clin Lab Haematol; 2006 Feb; 28(1):36-9. PubMed ID: 16430458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer.
    Fontana A; Galli L; Fioravanti A; Orlandi P; Galli C; Landi L; Bursi S; Allegrini G; Fontana E; Di Marsico R; Antonuzzo A; D'Arcangelo M; Danesi R; Del Tacca M; Falcone A; Bocci G
    Clin Cancer Res; 2009 Aug; 15(15):4954-62. PubMed ID: 19622584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor.
    El Tarhouny S; Seefeld M; Fan AX; Hahn S; Holzgreve W; Zhong XY
    Cytokine; 2008 Oct; 44(1):65-9. PubMed ID: 18691902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Villasante A; Pacheco A; Pau E; Ruiz A; Pellicer A; Garcia-Velasco JA
    Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative GMCSF limits the proangiogenic plasma protein changes associated with colorectal cancer resection.
    Shantha Kumara HM; Kirman I; Feingold D; Cekic V; Nasar A; Arnell T; Balik E; Hoffman A; Baxter R; Conte S; Whelan RL
    Eur J Surg Oncol; 2009 Mar; 35(3):295-301. PubMed ID: 18782657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin and erythropoietin receptor in colorectal cancer.
    Chabowska AM; Sulkowska M; Chabowski A; Wincewicz A; Koda M; Sulkowski S
    Int J Surg Pathol; 2008 Jul; 16(3):269-76. PubMed ID: 18487221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women.
    Caccamo C; Nostro L; Giorgianni G; Mondello S; Crascì E; Frisina N; Buemi M
    J Reprod Med; 2007 Nov; 52(11):1035-9. PubMed ID: 18161402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.